SKBI...NICE growth/profit machine...Here's the kicker...
SKBI's new vaccine production plant will add $12M - $14M to the top line next year @ 70% margin. Recent Hubei acquisition will add approx $4-$6M to the top line next year at approx 40% margin. That's approx $10M EXTRA in gross profit next year not counting organic growth or anything else. That's more than Skystar has in gross profit for the first 6 months of this year ($7M) and first 6 month EPS is $0.49.
HUGE Q3 coming up also. SKBI could easily come in w/ $1.80 - $2 EPS for FY2010 and $3++ for FY2011 (based on approx 7.1M shares outstanding). Also, Skystar mentioned that they have enough cash on hand to complete the Jiangsu based micro-organism facility which they already have a deposit on. Micro-organisms = approx 70% profit margin. (The Jiangsu acquisition is projected to be completed in the third quarter of 2010, so we'll see what happens. That's only a couple of weeks away.)
Next year's estimated growth is mind boggling, especially when adding in organic growth and the Jiangsu based micro-organism facility if and when the acquisition is complete.
Current share price = $6.50.
Imagination sets in...
Information posted by 2morrowsGains is opinion only and should not to be taken as investment advice.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.